1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsApplications reviewed on a rolling basis throughout the year; notifications sent within 4-6 weeks of submission.
Innovation Grants Program is sponsored by Infiltrate Bio. Provides funding opportunities for tumor infiltration and related research areas through their adhesion biomarker platform. Invites researchers, innovators, and consortia to submit proposals that explore novel applications of tumor infiltration prediction in cell therapy development, immunotherapy optimization, or other relevant fields.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Innovation Grants Program | Infiltrate Bio Innovation Grants Program Ready to advance your research? Apply for our Innovation Grants Program and gain access to cutting-edge tumor infiltration prediction that could accelerate your cell therapy development process.
Advancing Immune Therapy Research This grant is open to researchers, academic institutions, biotech companies, and pharmaceutical partners looking to integrate cutting-edge tumor infiltration prediction technology into their work. Applicants should have a strong scientific rationale and a clear plan for utilizing Infiltrate Bio's adhesion biomarker platform. Applications are reviewed on a rolling basis throughout the year.
Submit a 250-word proposal outlining your project objectives, research plan, and relevance to immune infiltration. Review cycles occur on a rolling basis with notifications sent within 4-6 weeks of submission. Our Innovation Grants support pilot studies analyzing primary T cells, CAR-T cells, PBMCs, or other immune cell populations.
Infiltration biomarker analysis service with our adhesion chromatography platform Up to 20 immune cell samples per pilot study Comprehensive analysis report with infiltration predictions, adhesion metrics, and expert interpretation Consultation on experimental design, data analysis, and results interpretation All samples must be submitted to Infiltrate Bio within 3 months of grant acceptance Accepted Sample Types (choose one category per application) Primary T cells: CD4+, CD8+, or mixed T cell populations Engineered cells: CAR-T, TCR-T, or other genetically modified immune cells PBMCs: Peripheral blood mononuclear cells or other immune cell preparations Open to researchers affiliated with academic institutions, biotechnology companies, or pharmaceutical organizations Grant recipients are expected to share results through publication, conference presentation, or poster presentation at a relevant scientific conference within 12 months of grant acceptance Applications are accepted on a rolling basis.
Start your research innovation today. Research Area * Select research area Industry * Select industry Sample Type * Select sample type I agree to the Terms and Conditions of the Innovation Grants Program * Terms and Conditions Apply.
Key questions and narrative sections extracted from the solicitation.
First Name, Last Name, Email Address, Organization, Job Title
Research Area (select from dropdown)
Industry (select from dropdown)
Sample Type (choose one: Primary T cells, Engineered cells such as CAR-T or TCR-T, or PBMCs)
Project Description: 250-word proposal outlining project objectives, research plan, and relevance to immune infiltration
According to the current listing, eligibility includes: Researchers, academic institutions, biotech companies, and pharmaceutical partners. Confirm the full requirements in the official notice before applying.
Innovation Grants Program is funded by Infiltrate Bio. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
NSF 26-517 replaces the core solicitations of Environmental Biology, Integrative Organismal Systems and Molecular and Cellular Biosciences with a single directorate-wide opportunity. Proposals are accepted anytime, sorted centrally by NSF rather than targeted by the PI, and reorganized under three inquiry areas. Here is what the $280 million actually buys, why the loss of program targeting cuts both ways, and what to do before the September 16 webinar.
Read articleThe Hewlett Foundation's Emerging Technology and Security Initiative commits $20 million a year through 2031 across AI, biotechnology, and quantum computing security. Its 2026 exploratory grants went to thirteen named institutions with no open call. For organizations outside that list, the path in runs through a specific set of moves — and the five-year term starting in 2027 is the window.
Read article